Compare BN & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BN | MCK |
|---|---|---|
| Founded | 1997 | 1833 |
| Country | Canada | United States |
| Employees | 250000 | N/A |
| Industry | Other Consumer Services | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 101.3B | 99.7B |
| IPO Year | N/A | 1995 |
| Metric | BN | MCK |
|---|---|---|
| Price | $45.45 | $763.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 14 |
| Target Price | $49.87 | ★ $952.92 |
| AVG Volume (30 Days) | ★ 5.2M | 1.1M |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.58% | 0.40% |
| EPS Growth | N/A | ★ 49.22 |
| EPS | N/A | ★ 38.38 |
| Revenue | N/A | ★ $112,084,000,000.00 |
| Revenue This Year | N/A | $14.94 |
| Revenue Next Year | $16.74 | $8.21 |
| P/E Ratio | $93.92 | ★ $19.93 |
| Revenue Growth | N/A | ★ 3.11 |
| 52 Week Low | $37.93 | $637.00 |
| 52 Week High | $74.20 | $999.00 |
| Indicator | BN | MCK |
|---|---|---|
| Relative Strength Index (RSI) | 51.86 | 40.97 |
| Support Level | $45.43 | $726.86 |
| Resistance Level | $48.10 | $776.14 |
| Average True Range (ATR) | 1.20 | 22.27 |
| MACD | -0.21 | 4.63 |
| Stochastic Oscillator | 29.69 | 47.45 |
Brookfield Corp is an investment firm focused on building long-term wealth for institutions and individuals, operating through seven segments: Asset Management, Wealth Solutions, Renewable Power and Transition, Infrastructure, Private Equity (which generates the highest revenue), Real Estate, and Corporate Activities. The company invests in real assets that form the backbone of the economy to deliver risk-adjusted returns to stakeholders, with the majority of its revenue coming from Asset Management. It has a presence across the United Kingdom, the United States (which contributes the highest revenue), Australia, Canada, Brazil, India, Colombia, Germany, other parts of Europe, other parts of Asia, and additional countries.
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.